Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neel K Gupta

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
New meets old: a case study and review of novel therapeutics for the treatment of CLL in older patientsNeel K Gupta, Charalambos Andreadis
Blood|August 22, 2013
How I treat CNS lymphomasJames L Rubenstein, Neel K Gupta, Gabriel N Mannis, et al.
Cancer Cytopathology|April 29, 2020
Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphomaSrishti Gupta, Steven R Long, Yasodha Natkunam, et al.
Leukemia & Lymphoma|February 24, 2021
Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapyMichael S Binkley, Susan M Hiniker, Sheren Younes, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
Blood Cancer Discovery|January 11, 2022
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished ImmunityTanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, et al.
Blood Advances|April 30, 2025
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
Science Translational Medicine|November 11, 2016
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNAFlorian Scherer, David M Kurtz, Aaron M Newman, et al.
The Journal of Experimental Medicine|June 20, 2020
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trialMatthew J Frank, Michael S Khodadoust, Debra K Czerwinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell LymphomaDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
New meets old: a case study and review of novel therapeutics for the treatment of CLL in older patientsNeel K Gupta, Charalambos Andreadis
Blood|August 22, 2013
How I treat CNS lymphomasJames L Rubenstein, Neel K Gupta, Gabriel N Mannis, et al.
Cancer Cytopathology|April 29, 2020
Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphomaSrishti Gupta, Steven R Long, Yasodha Natkunam, et al.
Leukemia & Lymphoma|February 24, 2021
Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapyMichael S Binkley, Susan M Hiniker, Sheren Younes, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
Blood Cancer Discovery|January 11, 2022
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished ImmunityTanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, et al.
Blood Advances|April 30, 2025
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
Science Translational Medicine|November 11, 2016
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNAFlorian Scherer, David M Kurtz, Aaron M Newman, et al.
The Journal of Experimental Medicine|June 20, 2020
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trialMatthew J Frank, Michael S Khodadoust, Debra K Czerwinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell LymphomaDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Pageof 1